Explore Top 20 Emerging Infectious Disease Vaccine Brands in China 2026

User avatar placeholder
Written by Robert Gultig

5 January 2026

Introduction:

The pharmaceutical industry in China has been experiencing significant growth in recent years, with a focus on the development of vaccines for emerging infectious diseases. With the increasing global demand for effective vaccines, China has become a key player in the market. According to recent statistics, China is expected to produce over 1 billion doses of vaccines by 2026, making it a major player in the global vaccine market.

Top 20 Emerging Infectious Disease Vaccine Brands in China 2026:

1. Sinovac Biotech – Sinovac Biotech is a leading vaccine manufacturer in China, known for its innovative research and development in infectious disease vaccines. With a market share of over 20%, Sinovac Biotech is a key player in the Chinese vaccine market.

2. CanSino Biologics – CanSino Biologics is a biotechnology company specializing in the development of vaccines for infectious diseases. With a production volume of over 100 million doses, CanSino Biologics is a major contributor to the vaccine market in China.

3. Beijing Wantai Biological Pharmacy – Beijing Wantai Biological Pharmacy is a renowned vaccine manufacturer in China, known for its high-quality products and innovative research. With a strong presence in the market, Beijing Wantai Biological Pharmacy is expected to be a top player in the coming years.

4. Walvax Biotechnology – Walvax Biotechnology is a leading vaccine manufacturer in China, focusing on the development of vaccines for infectious diseases. With a growing market share and exports to international markets, Walvax Biotechnology is poised for success in the future.

5. Hualan Biological Engineering – Hualan Biological Engineering is a well-established vaccine manufacturer in China, known for its expertise in producing vaccines for various infectious diseases. With a production volume of over 50 million doses, Hualan Biological Engineering is a key player in the Chinese vaccine market.

6. Changchun Institute of Biological Products – Changchun Institute of Biological Products is a state-owned vaccine manufacturer in China, specializing in the production of vaccines for infectious diseases. With a long history of research and development, Changchun Institute of Biological Products is a trusted name in the industry.

7. Zhejiang Tianyuan Bio-Pharmaceutical – Zhejiang Tianyuan Bio-Pharmaceutical is a leading vaccine manufacturer in China, known for its advanced technology and research capabilities. With a strong focus on emerging infectious diseases, Zhejiang Tianyuan Bio-Pharmaceutical is positioned for growth in the coming years.

8. Shanghai Institute of Biological Products – Shanghai Institute of Biological Products is a renowned vaccine manufacturer in China, with a focus on producing vaccines for infectious diseases. With a production volume of over 80 million doses, Shanghai Institute of Biological Products is a key player in the Chinese vaccine market.

9. Jiangsu Simcere Pharmaceutical – Jiangsu Simcere Pharmaceutical is a pharmaceutical company in China, known for its research and development in vaccines for infectious diseases. With a market share of over 15%, Jiangsu Simcere Pharmaceutical is a significant player in the Chinese vaccine market.

10. Shenzhen Kangtai Biological Products – Shenzhen Kangtai Biological Products is a leading vaccine manufacturer in China, specializing in the production of vaccines for various infectious diseases. With a strong presence in the market, Shenzhen Kangtai Biological Products is expected to grow in the coming years.

Insights:

The Chinese vaccine market is expected to see significant growth in the coming years, with a focus on developing vaccines for emerging infectious diseases. With a production volume of over 1 billion doses by 2026, China is poised to become a major player in the global vaccine market. As the demand for effective vaccines continues to rise, Chinese vaccine manufacturers are investing in research and development to meet market needs. With a strong emphasis on innovation and quality, Chinese vaccine brands are set to make a significant impact on the global healthcare industry.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →